Jun Guo
Hebei Medical University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Peking University(CN)Shantou University(CN)Peking University Cancer Hospital(CN)Yue Bei People's Hospital(CN)Xingtai People's Hospital(CN)Xiyuan Hospital(CN)Ministry of Education(ET)Xijing Hospital(CN)The Fourth People's Hospital of Ningxia Hui Autonomous Region(CN)University of Pennsylvania(US)
Publications by Year
Research Areas
Cutaneous Melanoma Detection and Management, Cancer Immunotherapy and Biomarkers, Melanoma and MAPK Pathways, CAR-T cell therapy research, Immunotherapy and Immune Responses
Most-Cited Works
- → Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma(2013)1,903 cited
- → Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: A study of 522 consecutive cases(2011)399 cited
- → Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets(2019)326 cited
- → Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody–Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma(2020)271 cited
- → Large-Scale Analysis of KIT Aberrations in Chinese Patients with Melanoma(2011)251 cited
- → Phase II Randomized Trial Comparing High-Dose IFN-α2b with Temozolomide Plus Cisplatin as Systemic Adjuvant Therapy for Resected Mucosal Melanoma(2013)197 cited